Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire.
Modulation of kallikrein-kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function.
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders.
Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis.
Purinergic Signaling and the Functioning of the Nervous System Cells.
Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.
Improving Fatigue and Depression in Individuals With Multiple Sclerosis Using Telephone-Administered Physical Activity Counseling.
Therapeutic strategies targeting B-cells in multiple sclerosis.
Hunting for autoantibodies in multiple sclerosis.
Multiple sclerosis in Isfahan, Iran: an update.
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
Multiple sclerosis for nurse practitioners.
Prevalence and incidence of Multiple Sclerosis in Campobasso (Molise region chieftown, southern Italy).
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis.
MS patients must have access to the best treatment options.
Myelination, oligodendrocytes, and serious mental illness.
The Role of Pregnancy-Associated Hormones in the Development and Function of Regulatory B Cells.
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.
Clinical Reasoning: An unusual cause of transverse myelitis?
The Multiple Sclerosis-Fatigue Self- Efficacy (MS-FSE) scale: initial validation.
Pages
« first
‹ previous
…
573
574
575
576
577
578
579
580
581
…
next ›
last »